HATAPHAR RECEIVES “TOP 10 MOST REPUTABLE PHARMACEUTICAL MANUFACTURING COMPANIES IN VIETNAM 2025” AWARD

On January 8, 2026, HATAPHAR officially received the “Top 10 Most Reputable Pharmaceutical Manufacturing Companies [...]

09
Jan
Resolution of the Company’s Board of Directors Meeting dated July 24th, 2026
24 July, 2026

[...]

Resolution on the implementation of the 2026 plan on share issuance to increase share capital from owner’s equity
24 July, 2026

[...]

Report on Corporate Governance ( first half of 2026)
16 July, 2026

[...]

Ha Tay Pharmaceutical Honored with “Disclosure Best Practice 2026”

Ha Tay Pharmaceutical Joint Stock Company (stock code: DHT) has recently been honored with the [...]

08
Jul
Mr. MASAYUKI TANAKA

[...]

01
Jul
Mr. Dinh Nam Ha

[...]

01
Jul
DHT CHESS TOURNAMENT 2026 RECAP: HONORING OUR YOUNG MASTERS

On May 31st, the DHT Chess Tournament 2026 successfully took place at the Manufacturing Factory [...]

02
Jun
Resolution of the Company’s Board of Directors Meeting dated May 27, 2026
28 May, 2026

[...]

Resolution on the extension of credit facilities at Shinhan Bank and BIDV
28 May, 2026

[...]

HA TAY PHARMACEUTICAL ORGANIZES 2026 ANNUAL HEALTH CHECK-UPS FOR EMPLOYEES

From May 13th to May 16th, Ha Tay Pharmaceutical collaborated with Ha Dong General Hospital [...]

18
May